Alpha Cognition Inc. Operating Expenses
Alpha Cognition Inc. (ACOG) reported Operating Expenses of $13.46 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2026-08-13
- Alpha Cognition Inc. operating expenses for the quarter ending 2026-06-30 was $13.46M, a 35.92% increase year-over-year.
- Alpha Cognition Inc. operating expenses for the quarter ending 2026-03-31 was $11.63M, a 83.62% increase year-over-year.
- Alpha Cognition Inc. operating expenses for the quarter ending 2025-06-30 was $9.90M, a 308.93% increase year-over-year.
- Alpha Cognition Inc. operating expenses for the quarter ending 2025-03-31 was $6.33M.
- Alpha Cognition Inc. operating expenses for fiscal 2025 was $32.88M, a 173.72% increase from fiscal 2024.
- Alpha Cognition Inc. operating expenses for fiscal 2024 was $12.01M, a 20.87% increase from fiscal 2023.
- Alpha Cognition Inc. operating expenses for fiscal 2023 was $9.94M.
| Period end | Operating Expenses 3 month | Operating Expenses 6 month | Operating Expenses 9 month | Operating Expenses 12 month | Operating Expenses 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | $13.46M 10-Q · filed 2026-08-13 | $24.81M 10-Q · filed 2026-08-13 | |||
| 2026-03-31 | $11.63M 10-Q · filed 2026-05-14 | ||||
| 2025-12-31 | $32.88M 10-K · filed 2026-03-31 | ||||
| 2025-06-30 | $9.90M 10-Q · filed 2026-08-13 | $15.39M 10-Q · filed 2026-08-13 | $18.93M derived: sum of 3 quarters · filed 2026-08-13 | $21.41M derived: sum of 4 quarters · filed 2026-08-13 | |
| 2025-03-31 | $6.33M 10-Q · filed 2026-05-14 | $9.03M derived: sum of 2 quarters · filed 2026-05-14 | $11.51M derived: sum of 3 quarters · filed 2026-05-14 | $13.93M derived: sum of 4 quarters · filed 2026-05-14 | |
| 2024-12-31 | $2.69M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $5.18M derived: sum of 2 quarters · filed 2026-03-31 | $7.60M derived: sum of 3 quarters · filed 2026-03-31 | $12.01M 10-K · filed 2026-03-31 | $11.86M 10-K · filed 2025-03-31 |
| 2024-09-30 | $2.49M 10-Q · filed 2024-11-14 | $4.91M derived: sum of 2 quarters · filed 2024-11-14 | $9.32M 10-Q · filed 2024-11-14 | ||
| 2024-06-30 | $2.42M 10-Q · filed 2024-08-12 | $6.83M 10-Q · filed 2024-08-12 | |||
| 2023-12-31 | $2.42M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $5.19M derived: sum of 2 quarters · filed 2025-03-31 | $7.91M derived: sum of 3 quarters · filed 2025-03-31 | $9.94M 10-K · filed 2025-03-31 | |
| 2023-09-30 | $2.77M 10-Q · filed 2024-11-14 | $5.49M derived: sum of 2 quarters · filed 2024-11-14 | $7.52M 10-Q · filed 2024-11-14 | ||
| 2023-06-30 | $2.73M 10-Q · filed 2024-08-12 | $4.71M 10-Q · filed 2024-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |